Wellem

Shanghai, China Founded: 2014 • Age: 12 yrs
A chain of general clinics is operated in Shanghai, China.

About Wellem

Wellem is a Healthcare company based in Shanghai (China) founded in 2014. A chain of general clinics is operated in Shanghai, China. Wellem has raised $100 million across 2 funding rounds from investors including Stonebridge Capital, GX Capital and NLVC. Its focus areas include Clinic Chains and General Clinics. Its competitors include EC Healthcare, DistinctClinic and SinoUnited Health; 2 of its 3 listed competitors have raised funding.

Company details

Wellen was established in 2014 in Shanghai, China, within the healthcare sector. A network of general clinics is managed by the company, focusing on routine medical services such as consultations, diagnostics, and basic treatments. Operations are centered in urban areas of China, serving local populations with accessible primary care. Expansion efforts have been directed toward increasing clinic availability in the region.

  • Headquarters Shanghai, China
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website wellem.com
Key Metrics
  • Total Equity Funding
    $100M (USD)

    in 2 rounds

  • Latest Funding Round
    $100M (USD), Series C

    Oct 2018

  • Investors

Funding Insights of Wellem

Wellem has successfully raised a total of $100M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $100M
  • Total Rounds 2
  • Last Round Series C β€” $100M
  • Investors Count 6

All 2 funding rounds of Wellem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018$100MSeries C–Stonebridge Capital, GX Capital
–
Apr 2017Series A–ShenZhen GTJA Investment Group
–
Valuation history

6 investors in total: 6 institutional.

Investors in Wellem

Wellem has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Stonebridge Capital, GX Capital and NLVC.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage tech and life sciences focused VC & PE firm
stonebridge.co.krSeoul, South Korea
gxcapital.com.cn
Provider of early stage venture capital focused on technology companies
nlvc.comMenlo Park, United States
Medical industry focused VC firm
daltonventure.cnShanghai, China
szgig.com
Investments are made in technology-based businesses by this VC firm.
gsipventures.comNew York, United States
Premium access

Investor details for Wellem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Wellem

3 dated milestones of Wellem across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Wellem is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series C, of $100.0M.

Competitors of Wellem

Wellem has 3 listed competitors in our database, 2 of them funded. They include EC Healthcare, DistinctClinic and SinoUnited Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
echealthcare.com2005Kowloon, China
Medical artificial intelligence, diagnostic imaging, and related systems are provided.
distinctclinic.com2012Shenzhen, China$167.5M
A chain of general clinics is operated in Shenzhen, China.
sinounitedhealth.com.cn2011Shanghai, China$14.54M
Chain of general clinics
Premium access

Detailed competitors of Wellem

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Wellem

Wellem was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Wellem is headquartered in Shanghai, China.

Wellem is a funded company, having raised a total of $100M across 2 funding rounds to date.

Wellen was established in 2014 in Shanghai, China, within the healthcare sector. A network of general clinics is managed by the company, focusing on routine medical services such as consultations, diagnostics, and basic treatments. Operations are centered in urban areas of China, serving local populations with accessible primary care. Expansion efforts have been directed toward increasing clinic availability in the region.

Wellem's top competitors include EC Healthcare, DistinctClinic and SinoUnited Health.

Wellem has 6 investors. Key investors include Stonebridge Capital, GX Capital, NLVC, Dalton Venture, and Goldman Sachs Investment Partners.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available